Stephen J. Freedland MDProfessor, Division of Urology, Department of Surgery; Director, Center for Integrated Research in Cancer and Lifestyle; Co-Director, Cancer Genetics and Prevention Program; Cedars-Sinai Medical Center, Los Angeles, California; and Staff Physician, Section of Urology, Durham VA Medical Center, Durham, North Carolina
Dr. Stephen Freedland is now Director, Center for Integrated Research in Cancer and Lifestyle, Co-Director, Cancer Genetics and Prevention Program, Associate Director, Faculty Development, Cedars-Sinai, Los Angeles, CA. He was a Urologist within the Duke Prostate Center at Duke University. He is an Associate Professor of Surgery (Urology) and Pathology. He also holds an appointment at the Durham VA Hospital. He is Editor-in-Chief of Prostate Cancer and Prostatic Diseases and sits on the editorial board of numerous international journals in Urology. He specializes in the diagnosis, treatment, and long-term management of prostate cancer patients. He has extensive research interests in risk stratification, the role of obesity and nutrition in prostate cancer, and health disparities for prostate cancer. He completed his undergraduate at UCLA and then medical school at UC Davis. Following this, he completed his residency in Urology at UCLA and a urological oncology fellowship at Johns Hopkins. He currently runs an active research program with funding from the National Cancer Institute and the Department of Defense.
Recent Contributions to PracticeUpdate:
- Trends for Stage and Grade Group of Prostate Cancer in the US
- Milk and Other Dairy Foods in Relation to Prostate Cancer Recurrence
- Relationship Between BMI and PSA in Risk for Prostate Cancer
- Impact of Obesity on Outcomes After Radiotherapy for Prostate Cancer
- Obesity and Long-Term Survival After Radical Prostatectomy